United States Pediatric Vaccines Market Outlook, 2027 - $15+ Billion Opportunity Assessment with Shares by Disease Indication

News provided by

Sep 08, 2020, 15:45 ET

DUBLIN, Sept. 8, 2020 /PRNewswire/ -- The "United States Pediatric Vaccines Market 2020-2027" report has been added to ResearchAndMarkets.com's offering.

The United States pediatric vaccines market is projected to exceed US$ 15 Billion by 2027.

Growth in the United States pediatric vaccine market can be accredited to factors such as, increasing community acceptance, improved disease cognizance, growing government focus on vaccination programs, and increased government funding for vaccine development.

Report Scope

The Market Size of the United States Pediatric Vaccines Market with Seven Years Forecast
The Market Size of the Polio, Hepatitis B, Hepatitis A, Diphtheria, Tetanus & Pertussis (DTaP), Haemophilus Influenzae Type B (HIB), Pneumococcal Disease, Measles, Mumps, and Rubella (MMR), Varicella / Chicken Pox, Rotavirus, Influenza Pediatric with Seven Years Forecast
Detailed Market Share Assessment of the United States Pediatric Vaccines Market
Covers a Complete Analysis of the United States Pediatric Vaccines Doses Administered with Seven Years Forecast
Scrutinizes the United States Children Being Vaccinated with Pediatric Vaccines with Seven Years Forecast
Delivers Inclusive Insights on the Latest Pricing Trends and Analysis of the United States Pediatric Vaccines
Delivers a Comprehensive Outline of the Preventable Diseases and their Vaccines Available in the Market
Detailed Insights into the Regulatory Framework of the United States Influenza Vaccines Market
Delivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the United States Pediatric Vaccines Market
A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Business Overview, and Recent Development

United States Pediatric Vaccines Market 2020-2027 provides an exclusive tool for assessing the market, highlighting prospects, supporting strategic and positive decision-making. This report identifies that in this rapidly-evolving and competitive situation, up-to-date information and statistics are crucial to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on the United States pediatric vaccines market. The report also provides a clear insight into current and future developments of the United States pediatric vaccines market. Furthermore, this report provides a deep and thorough evaluation of the top pediatric vaccines by disease indication.

Based on disease indication, the top pediatric vaccines provide an in-depth analysis of the number of children being immunized, doses administered, market size, and analysis. The report provides historical market data for 2015-2019, and forecasts from 2020 till 2027.

An all-inclusive examination has been done on the pricing, distribution, demand, and preventable diseases and their vaccines available in the market.

Additionally, this up-to-date report describes a clear view of the regulatory framework of the United States pediatric vaccines market. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.

The report also analyses detailed profiles of innovative and leading players with information on business overview, companies' vaccines portfolio, and the latest developments.

Key Questions Addressed by the Report

What is the current size of the overall pediatric vaccine market in the United States?
How much will this market be worth from 2020 to 2027?
Which pediatric vaccines provide the highest market share?
How many children being immunized with pediatric vaccines in the US during 2015-2027?
What are the key marketed pediatric vaccines available in the United States?
How many pediatric vaccine doses administered in the US during 2015-2027?
What are the major drivers of the United States pediatric vaccines market?
What are the major inhibitors of the United States pediatric vaccines market?
What is the regulatory framework in the United States pediatric vaccines market?
Who are the top market players? What are their happenings, vaccines, current developments, and scenarios?
How is the market predicted to develop in the future?

Key Topics Covered

1. Executive Summary

2. United States Pediatric Vaccines Market Analysis, 2015-2019 and Forecast, 2020-2027

3. United States Pediatric Vaccines Market Share and Y-o-Y Growth (%)

4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Pediatric Vaccines Market - By Disease Indication (2015-2027)
5.1 Polio
5.1.1 Doses Administered (Volume)
5.1.2 Number of Children Being Vaccinated (Volume)
5.1.3 Market Size and Forecast (Value)
5.2 Hepatitis B
5.3 Hepatitis A
5.4 Diphtheria, Tetanus & Pertussis (DTaP)
5.5 Haemophilus Influenzae Type B (HIB)
5.6 Pneumococcal
5.7 Measles, Mumps & Rubella (MMR)
5.8 Varicella / Chicken Pox
5.9 Rotavirus
5.10 Influenza Pediatric

6. Preventable Diseases and their Vaccines Available in the Market

7. United States Pediatric Vaccines Pricing Trends and Analysis

8. Regulatory Framework of the United States Pediatric Vaccines Market

9. Key Companies Analysis
9.1 Sanofi Pasteur
9.2 GlaxoSmithKline (GSK)
9.3 Merck
9.4 Pfizer
9.5 Grifols

For more information about this report visit https://www.researchandmarkets.com/r/iy43wc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets